Next Article in Journal
1-Benzyloxymethyl-2,2,4,4-tetrachloro-8-oxabicyclo[3.2.1]oct-6-en-3-one
Previous Article in Journal
2-(b-D-Ribofuranosyl)-4-(p-tolylazo)-5-trifluoromethyl-2,4-dihydropyrazol-3-one
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

endo-N-(5,5-Dimethyl-6-methylene-bicyclo[2.2.1]hept-2-yl)-4-methyl-benzenesulfonamide

by
Concepción Badía
,
Juan M. Castro
,
Pablo J. Linares-Palomino
,
Sofía Salido
,
Joaquín Altarejos
*,
Manuel Nogueras
and
Adolfo Sánchez
Departamento de Química Inorgánica y Orgánica, Facultad de Ciencias Experimentales,Universidad de Jaén, 23071 Jaén, Spain.
*
Author to whom correspondence should be addressed.
Molbank 2004, 2004(1), M389; https://doi.org/10.3390/M389
Submission received: 16 January 2004 / Accepted: 26 March 2004 / Published: 29 March 2004
Molbank 2004 m389 i001
p-Toluenesulfonic acid (35 mg, 0.20 mmol) was added to a stirred mixture of campholenic aldehyde (1) (725 mg, 3.81 mmol) and p-toluenesulfonamide (1.22 g, 6.96 mmol) in toluene (20 mL). Then a Dean-Stark trap device was fit and the reaction refluxed for 0.5 h. After that, the mixture was cooled to 0 oC, filtered through a silica gel pad and the solvent evaporated under reduced pressure to yield a residue (1.30g) which was purified by flash chromatography on silica gel, using a 2:1 Hexane/Et2O mixture as eluent, to give the title compound 2 (591 mg, 1.93 mmol, 51%).
Mp: 101.2–104.3 oC (White crystals, from hexane)
IR (KBr, n, cm-1): 3264 (N-H), 3062, 1656, 881 (C=C), 3062, 813 (Ar), 1337, 1164 (SO2), 667 (C-N).
1H NMR (300 MHz, CDCl3, d, ppm): 1.00 (3H, s, Mea-5’), 1.02 (3H, s, Meb-5’), 1.17–1.30 (2H, m, H-3’, H-7’), 1.70–1.82 (3H, m, H’-3’, H’-7’, H-4’), 2.34 (1H, br d, J=3.3 Hz, H-1’), 2.42 (3H, s, Me-4), 3.64–3.75 (1H, m, H-2’), 4.64 (1H, d, J=10.2 Hz, N-H), 4.67 (1H, s, CH2-6’), 4.85 (1H, s, CH2-6’), 7.30 (2H, d, J=8.3 Hz, H-3, H-5), 7.74 (2H, d, J=8.3 Hz, H-2, H-6). Some signals were assigned by means of 2D NMR experiments.
13C NMR (75 MHz, CDCl3, d, ppm): 138.20 (C-1), 126.96 (C-2), 129.57 (C-3), 143.18 (C-4), 21.43 (Me-4), 50.49 (C-1’), 51.93 (C-2’), 31.99* (C-3’), 47.40 (C-4’), 42.30 (C-5’), 158.03 (C-6’), 36.31* (C-7’), 106.69 (CH2-6’), 24.64 (Mea-5’), 29.41 (Meb-5’). Some signals were assigned by means of 2D NMR experiments.
*These signals may be interchanged.
MS (70 eV, m/z): 305 (M+, 4%), 240 (M+–SO2H, 14), 185 (3), 171 (3), 162 (4), 155 (Ts+, 12), 150 (M+–Ts, 17), 134 (M+–TsNH2, 23), 121 (M+–TsNH–Me, 39), 108 (72), 91 (MePh+, 100), 79 (26), 65 (42), 53 (17), 41 (35), 39 (37).

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

Acknowledgements

We wish to thank the Ministerio de Ciencia y Tecnología for financial support (R+D Project PPQ2000-1665) and the Ministerio de Educación, Cultura y Deporte for a fellowship to J. M. Castro.

Share and Cite

MDPI and ACS Style

Badía, C.; Castro, J.M.; Linares-Palomino, P.J.; Salido, S.; Altarejos, J.; Nogueras, M.; Sánchez, A. endo-N-(5,5-Dimethyl-6-methylene-bicyclo[2.2.1]hept-2-yl)-4-methyl-benzenesulfonamide. Molbank 2004, 2004, M389. https://doi.org/10.3390/M389

AMA Style

Badía C, Castro JM, Linares-Palomino PJ, Salido S, Altarejos J, Nogueras M, Sánchez A. endo-N-(5,5-Dimethyl-6-methylene-bicyclo[2.2.1]hept-2-yl)-4-methyl-benzenesulfonamide. Molbank. 2004; 2004(1):M389. https://doi.org/10.3390/M389

Chicago/Turabian Style

Badía, Concepción, Juan M. Castro, Pablo J. Linares-Palomino, Sofía Salido, Joaquín Altarejos, Manuel Nogueras, and Adolfo Sánchez. 2004. "endo-N-(5,5-Dimethyl-6-methylene-bicyclo[2.2.1]hept-2-yl)-4-methyl-benzenesulfonamide" Molbank 2004, no. 1: M389. https://doi.org/10.3390/M389

APA Style

Badía, C., Castro, J. M., Linares-Palomino, P. J., Salido, S., Altarejos, J., Nogueras, M., & Sánchez, A. (2004). endo-N-(5,5-Dimethyl-6-methylene-bicyclo[2.2.1]hept-2-yl)-4-methyl-benzenesulfonamide. Molbank, 2004(1), M389. https://doi.org/10.3390/M389

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop